General Atlantic's exit filing signals a complete unwinding of a once-significant position. Monitor for any additional insider selling or further institutional exits that could pressure the stock.
PHVS drugs
PHVS drug pipeline →Price Chart
How similar events traded
Executive Summary
General Atlantic filed Amendment No. 4 to its Schedule 13G for Pharvaris N.V., reporting a 0.6% stake (437,458 ordinary shares) held through General Atlantic PH B.V. The filing states that as of September 9, 2026, the group ceased to be a beneficial owner of more than 5% of shares, and this is an exit filing. The stake dropped from a prior above-5% level to below the 5% threshold, signaling a significant reduction in General Atlantic's position.
Key Financial Metrics
Key Facts
- General Atlantic and related entities filed Amendment No. 4 to Schedule 13G for Pharvaris N.V.
- As of November 12, 2026, the group beneficially owns 437,458 ordinary shares, representing 0.6% of outstanding shares.
- The filing states that as of September 9, 2026, the group ceased to be a beneficial owner of more than 5% of ordinary shares.
- This Amendment No. 4 is described as the final amendment and constitutes an exit filing.
- Percentage ownership based on 70,791,931 shares outstanding as of September 30, 2026.
- The prior filing (August 15, 2026) showed the group still above 5% (exact percentage not provided in context).
Financial Impact
General Atlantic reduced its stake from above 5% to 0.6%, representing a reduction of at least 4.4% of the company's shares.
Risk Factors
- Loss of a major institutional holder could reduce investor confidence and increase selling pressure.
- The exit may indicate the fund's view that the stock is fully valued or that better opportunities exist elsewhere.
- No new activist or strategic catalyst is implied by this passive exit.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000950142-26-003037 |
| Document: eh260840242_scha.htm | 0000950142-26-003037 |
| Document: 0000950142-26-003037-index-headers.html | 0000950142-26-003037 |
| Document: 0000950142-26-003037-index.html | 0000950142-26-003037 |
| Document: 0000950142-26-003037.txt | 0000950142-26-003037 |
Track record
51 reports on PHVS
15 of 18 bullish or bearish reports moved the stock their way by T+5. Best: +23.73% at T+20 after the Sep 17, 2026 report. 17 of 19 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $33.19 Now $32.44 −2.26% settles Nov 23
- Nov 13, 20263d ago SC 13G/A Bearish 5/10 Viewing Entry $33.59 Now $32.44 +3.42% settles Nov 23
- Nov 12, 20264d ago Press Release Bullish 7/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
- Nov 12, 20264d ago 6-K Neutral 4/10 No price data
- Nov 12, 20264d ago Press Release Neutral 5/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
- Sep 25, 20267w ago Insider Cluster Bearish 6/10 Entry $32.02 to $31.19 Now $32.44 −1.31% ▲ +2.59% +2.37% vs SPY
- Sep 24, 20267w ago Insider Cluster Bearish 7/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
- Sep 24, 20267w ago Insider Cluster Bearish 5/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
- Sep 23, 20267w ago Insider Cluster Bearish 6/10 Entry $33.07 to $31.72 Now $32.44 +1.91% ▲ +4.08% +3.41% vs SPY
- Sep 21, 20268w ago Insider Cluster Bearish 5/10 Entry $36.02 to $31.91 Now $32.44 +9.94% ▲ +11.41% +10.39% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers